Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherFP Watch

Bronchiolitis

Graham Worrall
Canadian Family Physician May 2008; 54 (5) 742-743;
Graham Worrall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Bronchiolitis is the most common lower respiratory tract infection in infants. It is the leading cause of hospitalization of infants younger than age 1, and more than 80% of children hospitalized are younger than 6 months of age. Disease severity is directly related to the size and maturity of the infant. In Canada between 1980 and 2000, the rate of hospitalization for bronchiolitis increased, especially among children younger than 6 months of age. The risk of death for a healthy infant with bronchiolitis is less than 0.5%, but the risk is much higher for children with congenital heart disease (3.5%) and chronic lung disease (3.45%). Respiratory syncytial virus (RSV) is responsible for 70% of bronchiolitis; this figure rises to 80% to 100% in winter epidemics.

  • Each year, 1% to 2% of children younger than 12 months of age are hospitalized for bronchiolitis. Only 1% of hospitalized children die of the illness.

  • The mean duration of hospital stay is 3 to 4 days.

  • Bronchiolitis occurs mainly during winter.

  • The incidence of bronchiolitis is increasing.

  • Around 70% of cases are due to RSV.

Clinical course and diagnosis

Bronchiolitis is a virally induced bronchiolar inflammation. Its diagnosis is purely clinical and tests are of little value. A wheezing infant is assumed to have bronchiolitis; tachypnea, expiratory wheezing, flaring of the nostrils, and intercostal chest wall retractions are typical. Mean duration of illness is approximately 10 days.

  • Mean duration of illness is 10 days.

  • Consider hospitalization if any of the following qualities apply to the infant:

    • – premature,

    • – < 3 months old,

    • – respiratory rate of > 70 breaths/min,

    • – oxygen saturation of < 92%,

    • – cardiopulmonary disease,

    • – immunodeficient, or

    • – lethargic.

Treatment

Systematic reviews conclude that there is little evidence for any drug in treating patients with bronchiolitis.

Antibiotics

As bronchiolitis is almost always caused by infection of susceptible children with RSV, antibiotics are of no use.

β-Agonists and anticholinergic therapy

Reviews conclude that β-agonists produce only a modest short-term improvement; their use has no effect on hospitalization rate. There is insufficient evidence to support the use of epinephrine for bronchiolitis. The combination of ipratropium and a β2-agonist produced some improvement, but there is not enough evidence to support the uncritical use of anticholinergic therapy for wheezing infants.

Corticosteroids

The evidence for beneficial effects of corticosteroids for treating bronchiolitis is weak compared with that for treating croup. Any beneficial effect is likely to be small and must be weighed against the acute adverse effects of corticosteroids. A meta-analysis (Garrison et al) suggests corticosteroids can be effective. A Cochrane Review (Patel et al) that suggested they had no benefit was subsequently withdrawn. Two studies have found that the combination of dexamethasone and salbutamol result in a swifter resolution of bronchiolitis symptoms than either agent alone.

Antiviral and immunoglobulin agents

Administration of the antiviral ribavirin compared with placebo does not reduce rates of respiratory deterioration or death. Immunoglobulin agents have been tried for children at high risk of underlying congenital heart disease or bronchopulmonary dysplasia. The incidence of hospitalization (number needed to treat = 17) and the incidence of admission to the intensive care unit (number needed to treat = 50) were halved, but there was no reduced hospital stay, duration of ventilation, or duration of treatment with supplementary oxygen. There is currently no good evidence for the use of these agents to treat moderate or severe cases of bronchiolitis.

Other therapies

Supportive therapy is the mainstay of treatment. Most children have only mild infections and recover with nursing care alone. Severely ill children require oxygen supplementation, intubation, and assisted ventilation. When confronted with an infant who has symptoms of bronchiolitis, the FP needs to assess whether or not the child is ill enough to go to hospital.

  • Possible effective treatments include the following:

    • – nebulized epinephrine,

    • – β-agonists,

    • – ipratropium,

    • – corticosteroids, and

    • – oxygen.

  • Treatments of little value include the following:

    • – ribavirin,

    • – antibiotics, and

    • – nursing measures.

Prophylaxis

Apart from small and limited groups of at-risk children who might benefit from passive immunoglobulins, there seems to be no effective way of preventing bronchiolitis due to RSV infection in most children. There is no effective RSV vaccine.

In severely at-risk children, immunization with RSV immunoglobulin or monoclonal antibody reduces rates of admission to hospital and intensive care. The American Academy of Pediatrics currently recommends that monoclonal antibody (palivizumab) or RSV immunoglobulin should be given to the following:

  • children < 2 years of age with chronic lung disease;

  • preterm infants born < 28 weeks;

  • infants born at 29 to 32 weeks’ gestation when experiencing their first RSV season; and

  • infants born at 32 to 35 weeks who are attending a child care centre, have school-aged siblings, are exposed to environmental pollution, or have abnormalities of the airways or severe neuromuscular problems.

  • Possible prophylaxis in premature and high-risk infants includes the following:

    • – monoclonal antibody, and

    • – RSV immunoglobulin.

    • No effective RSV vaccine exists.

Footnotes

  • Adapted from: Worrall G. There’s a lot of it about: acute respiratory infection in primary care. Abingdon, Engl: Radcliffe Publishing Ltd; 2006.

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. Agency for Healthcare Research and Quality [website]Management of bronchiolitis in infants and children. Evidence report/technology assessment: number 69Rockville, MDAgency for Healthcare Research and Quality2003Available from: www.ahrq.gov/clinic/epcsums/broncsum.htmAccessed 2008 Mar 10
  2. EverardMLBaraAKurianMElliottTMDucharmeFMayoweVAnticholinergic drugs for wheeze in children under the age of two yearsCochrane Database Syst Rev20053CD001279
  3. GarrisonMMChristakisDAHarveyECummingsPDavisRLSystematic corticosteroids for infant bronchiolitis: a meta-anlaysisPediatrics20001054e44
    OpenUrlAbstract/FREE Full Text
  4. HartlingLWiebeNRussellKPatelHKlassenTPEpinephrine for bronchiolitisCochrane Database Syst Rev20041CD003123
  5. KellnerJDOhlssonAGadomskiAMWangEEBronchodilators for bronchiolitisCochrane Database Syst Rev20002CD001266
  6. PatelHPlattRLozanoJMWangEEGlucocorticosteroids for acute viral bronchiolitis in infants and young childrenCochrane Database Syst Rev20043CD004878
  7. Withdrawn in:PatelHPlattRLozanoJMCochrane Database Syst Rev20081CD004878
  8. WorrallGWorrallGBronchiolitisThere’s a lot of it about: acute respiratory infection in primary careAbingdon, EnglRadcliffe Publishing Ltd200690101
PreviousNext
Back to top

In this issue

Canadian Family Physician: 54 (5)
Canadian Family Physician
Vol. 54, Issue 5
1 May 2008
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bronchiolitis
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bronchiolitis
Graham Worrall
Canadian Family Physician May 2008, 54 (5) 742-743;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Bronchiolitis
Graham Worrall
Canadian Family Physician May 2008, 54 (5) 742-743;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical course and diagnosis
    • Treatment
    • Prophylaxis
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

FP Watch

  • Use of nonvitamin dietary supplements with prescription medications
  • Elliptical excision
  • Hospitalist care
Show more FP Watch

ARI Series

  • Croup
  • Influenza
Show more ARI Series

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire